Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategy
BSX logo

Boston Scientific's Net Sales Soar 12.3% to $14.24B in 2023, Fueled by Acquisitions and Organic Growth

BSX10-KFiling Date: 2/20/2024
Boston Scientific Corporation
Description

What this story covers

Boston Scientific reported strong 2023 financials with 12 point 3 percent net sales growth to 14 point 24 billion dollars, driven by strategic acquisitions and robust organic performance. Net income significantly increased to 1 point 57 billion dollars, while investments in R&D and M&A continue to shape future growth amid complex regulatory and competitive landscapes.

Story snapshot

CompanyBoston Scientific Corporation
TickerBSX
VariantStandard detailed
Duration26:56
Filing type10-K
PeriodAnnual 2023
IndustryHealthcare & Pharmaceuticals
Accession0000885725-24-000017

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in